Corrigendum to “Hypoxia-selective prodrug restrains tumor cells through triggering mitophagy and inducing apoptosis” [Europ. J. Med. Chem. 283 (2025) 17155]

IF 6 2区医学 Q1 CHEMISTRY, MEDICINAL

European Journal of Medicinal Chemistry Pub Date : 2025-06-19 DOI:10.1016/j.ejmech.2025.117881

Fangjie Wang, Lairong Song, Qianqian Xu, Ang Jia, Xiangwei Meng, Hongfei Jiang, Renshuai Zhang

引用次数: 0

Abstract

The authors regret < that in Fig. 5E, the concentration label was incorrectly marked as “10 μM”. The correct concentration should be “5 μM”. Additionally, the same concentration label in the Graphical Abstract needs to be updated to reflect this change>.

查看原文本刊更多论文

“低氧选择性前药通过触发线粒体自噬和诱导细胞凋亡来抑制肿瘤细胞”的更正[欧洲]。J.医学化学。283 (2025)17155]

作者感到遗憾<；在图5E中，浓度标签错误地标注为“10 μM”。正确的浓度为5 μM。此外，图形摘要中的相同浓度标签需要更新以反映这一变化。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

European Journal of Medicinal Chemistry 化学-医药化学

CiteScore

11.70

自引率

9.00%

发文量

863

审稿时长

29 days

期刊介绍： The European Journal of Medicinal Chemistry is a global journal that publishes studies on all aspects of medicinal chemistry. It provides a medium for publication of original papers and also welcomes critical review papers. A typical paper would report on the organic synthesis, characterization and pharmacological evaluation of compounds. Other topics of interest are drug design, QSAR, molecular modeling, drug-receptor interactions, molecular aspects of drug metabolism, prodrug synthesis and drug targeting. The journal expects manuscripts to present the rational for a study, provide insight into the design of compounds or understanding of mechanism, or clarify the targets.